418 related articles for article (PubMed ID: 4332693)
1. Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.
Ungerstedt U
Acta Physiol Scand Suppl; 1971; 367():69-93. PubMed ID: 4332693
[No Abstract] [Full Text] [Related]
2. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.
Ungerstedt U
Acta Physiol Scand Suppl; 1971; 367():49-68. PubMed ID: 4332692
[No Abstract] [Full Text] [Related]
3. Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system.
Ungerstedt U
Acta Physiol Scand Suppl; 1971; 367():95-122. PubMed ID: 4332694
[No Abstract] [Full Text] [Related]
4. Actions of levodopa and dopamine in the central nervous system.
Sourkes TL
JAMA; 1971 Dec; 218(13):1909-11. PubMed ID: 4398939
[No Abstract] [Full Text] [Related]
5. Increased acoplasmic transport of H3-dopamine in nigro-neostriatal neurons after reserpine.
Fibiger HC; McGeer EG
Life Sci; 1973 Dec; 13(11):1565-71. PubMed ID: 4588712
[No Abstract] [Full Text] [Related]
6. Use of 6-hydroxydopamine to create lesions in catecholamine neurons in rats.
Mendez JS; Finn BW
J Neurosurg; 1975 Feb; 42(2):166-73. PubMed ID: 234524
[TBL] [Abstract][Full Text] [Related]
7. Central actions of dopa and dopamine.
Sourkes TL
Rev Can Biol; 1972; 31():Suppl:153-68. PubMed ID: 4403289
[No Abstract] [Full Text] [Related]
8. Denervation-like postsynaptic supersensitivity to dopamine agonists induced by microinjection of colchicine into the substantia nigra pars compacta.
Kamata K; Kameyama T; Okuyama S; Hashimoto S; Aihara H
Brain Res; 1986 Mar; 367(1-2):1-7. PubMed ID: 3008917
[TBL] [Abstract][Full Text] [Related]
9. Behavioral correlates of dopaminergic supersensitivity.
Iversen SD; Creese I
Adv Neurol; 1975; 9():81-92. PubMed ID: 1170717
[No Abstract] [Full Text] [Related]
10. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
11. Behavioural sequelae of dopaminergic degeneration: postsynaptic supersensitivity?
Creese I; Iversen SD
Psychopharmacol Bull; 1975 Oct; 11(4):12-3. PubMed ID: 1197588
[No Abstract] [Full Text] [Related]
12. A model for the quantitative study of central dopaminergic and serotoninergic activity.
Bieger D; Larochelle L; Hornykiewicz O
Eur J Pharmacol; 1972 Apr; 18(1):128-36. PubMed ID: 4555562
[No Abstract] [Full Text] [Related]
13. Drug-induced rotation in rats without lesions: behavioral and neurochemical indices of a normal asymmetry in nigro-striatal function.
Jerussi TP; Glick SD
Psychopharmacology (Berl); 1976 Jun; 47(3):249-60. PubMed ID: 823560
[TBL] [Abstract][Full Text] [Related]
14. 7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.
Kikuchi T; Tottori K; Uwahodo Y; Hirose T; Miwa T; Oshiro Y; Morita S
J Pharmacol Exp Ther; 1995 Jul; 274(1):329-36. PubMed ID: 7616416
[TBL] [Abstract][Full Text] [Related]
15. The effect of LSD and 2-bromo LSD on the striatal DOPA accumulation after decarboxylase inhibition in rats.
Persson SA
Eur J Pharmacol; 1977 May; 43(1):73-83. PubMed ID: 16756
[TBL] [Abstract][Full Text] [Related]
16. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
LaHoste GJ; Marshall JF
Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
[TBL] [Abstract][Full Text] [Related]
17. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
Costall B; Naylor RJ; Pycock C
Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
[TBL] [Abstract][Full Text] [Related]
18. Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones.
Bunney BS; Aghajanian GK; Roth RH
Nat New Biol; 1973 Sep; 245(143):123-5. PubMed ID: 4518113
[No Abstract] [Full Text] [Related]
19. [Effects of different doses of apomorphine on the glutamate decarboxylase activity of the substantia nigra and the medial basal hypothalamus].
Giammona G; Pattà F; Sambataro V; Reggio A; Rampello L; Di Giorgio RM; Maccagnano C; Condorelli DF; Nicoletti F
Boll Soc Ital Biol Sper; 1981 Oct; 57(20):2074-9. PubMed ID: 7317201
[TBL] [Abstract][Full Text] [Related]
20. Time-dependent changes in the sensitivity of dopamine neurons to low doses of apomorphine following amphetamine infusion.
Lee TH; Ellinwood EH
Brain Res; 1989 Mar; 483(1):17-29. PubMed ID: 2495842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
